210 related articles for article (PubMed ID: 35065168)
41. Using mouse models to unlock the secrets of non-synonymous RNA editing.
Jinnah H; Ulbricht RJ
Methods; 2019 Mar; 156():40-45. PubMed ID: 30827465
[TBL] [Abstract][Full Text] [Related]
42. The evolution and adaptation of A-to-I RNA editing.
Yablonovitch AL; Deng P; Jacobson D; Li JB
PLoS Genet; 2017 Nov; 13(11):e1007064. PubMed ID: 29182635
[TBL] [Abstract][Full Text] [Related]
43. The role of A-to-I RNA editing in cancer development.
Xu X; Wang Y; Liang H
Curr Opin Genet Dev; 2018 Feb; 48():51-56. PubMed ID: 29127844
[TBL] [Abstract][Full Text] [Related]
44. A biochemical landscape of A-to-I RNA editing in the human brain transcriptome.
Sakurai M; Ueda H; Yano T; Okada S; Terajima H; Mitsuyama T; Toyoda A; Fujiyama A; Kawabata H; Suzuki T
Genome Res; 2014 Mar; 24(3):522-34. PubMed ID: 24407955
[TBL] [Abstract][Full Text] [Related]
45. Mouse models to elucidate the functional roles of adenosine-to-inosine editing.
Rula EY; Emeson RB
Methods Enzymol; 2007; 424():333-67. PubMed ID: 17662849
[TBL] [Abstract][Full Text] [Related]
46. High-throughput screening for functional adenosine to inosine RNA editing systems.
Pokharel S; Beal PA
ACS Chem Biol; 2006 Dec; 1(12):761-5. PubMed ID: 17240974
[TBL] [Abstract][Full Text] [Related]
47. Adenosine to inosine editing by ADAR2 requires formation of a ternary complex on the GluR-B R/G site.
Jaikaran DC; Collins CH; MacMillan AM
J Biol Chem; 2002 Oct; 277(40):37624-9. PubMed ID: 12163487
[TBL] [Abstract][Full Text] [Related]
48. Increased adenosine-to-inosine RNA editing in rheumatoid arthritis.
Vlachogiannis NI; Gatsiou A; Silvestris DA; Stamatelopoulos K; Tektonidou MG; Gallo A; Sfikakis PP; Stellos K
J Autoimmun; 2020 Jan; 106():102329. PubMed ID: 31493964
[TBL] [Abstract][Full Text] [Related]
49. Deciphering the functions and regulation of brain-enriched A-to-I RNA editing.
Li JB; Church GM
Nat Neurosci; 2013 Nov; 16(11):1518-22. PubMed ID: 24165678
[TBL] [Abstract][Full Text] [Related]
50. The effects of RNA editing in cancer tissue at different stages in carcinogenesis.
Kurkowiak M; Arcimowicz Ł; Chruściel E; Urban-Wójciuk Z; Papak I; Keegan L; O'Connell M; Kowalski J; Hupp T; Marek-Trzonkowska N
RNA Biol; 2021 Nov; 18(11):1524-1539. PubMed ID: 33593231
[TBL] [Abstract][Full Text] [Related]
51. Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis.
Liddicoat BJ; Hartner JC; Piskol R; Ramaswami G; Chalk AM; Kingsley PD; Sankaran VG; Wall M; Purton LE; Seeburg PH; Palis J; Orkin SH; Lu J; Li JB; Walkley CR
Exp Hematol; 2016 Oct; 44(10):947-63. PubMed ID: 27373493
[TBL] [Abstract][Full Text] [Related]
52. Computational approaches for detection and quantification of A-to-I RNA-editing.
Pinto Y; Levanon EY
Methods; 2019 Mar; 156():25-31. PubMed ID: 30465820
[TBL] [Abstract][Full Text] [Related]
53. A-to-I RNA editing - thinking beyond the single nucleotide.
Ganem NS; Lamm AT
RNA Biol; 2017 Dec; 14(12):1690-1694. PubMed ID: 28820319
[TBL] [Abstract][Full Text] [Related]
54. A Systematic Review of Common and Brain-Disease-Specific RNA Editing Alterations Providing Novel Insights into Neurological and Neurodegenerative Disease Manifestations.
Karagianni K; Pettas S; Christoforidou G; Kanata E; Bekas N; Xanthopoulos K; Dafou D; Sklaviadis T
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327657
[TBL] [Abstract][Full Text] [Related]
55. Perturbing A-to-I RNA editing using genetics and homologous recombination.
Staber CJ; Gell S; Jepson JE; Reenan RA
Methods Mol Biol; 2011; 718():41-73. PubMed ID: 21370041
[TBL] [Abstract][Full Text] [Related]
56. Identification of A-to-I RNA editing: dotting the i's in the human transcriptome.
Kiran A; Loughran G; O'Mahony JJ; Baranov PV
Biochemistry (Mosc); 2011 Aug; 76(8):915-23. PubMed ID: 22022965
[TBL] [Abstract][Full Text] [Related]
57. REIA: A database for cancer A-to-I RNA editing with interactive analysis.
Zhu H; Huang L; Liu S; Dai Z; Songyang Z; Weng Z; Xiong Y
Int J Biol Sci; 2022; 18(6):2472-2483. PubMed ID: 35414795
[TBL] [Abstract][Full Text] [Related]
58. Identification of substrates for adenosine deaminases that act on RNA.
Morse DP
Methods Mol Biol; 2004; 265():199-218. PubMed ID: 15103075
[TBL] [Abstract][Full Text] [Related]
59. A-to-I RNA editing and cancer: from pathology to basic science.
Gallo A; Galardi S
RNA Biol; 2008; 5(3):135-9. PubMed ID: 18758244
[TBL] [Abstract][Full Text] [Related]
60. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
